期刊文献+

以冷凝集素综合征为首发表现的LPL/WM一例

Lymphoplasmacytic lymphoma / Waldenstrom's macroglobulinemia with cold agglutinin syndrome: a case report
下载PDF
导出
摘要 淋巴浆细胞淋巴瘤/华氏巨球蛋白血症(LPL/WM)是少见的非霍奇金淋巴瘤,以淋巴浆细胞增生引起血清单克隆Ig M增高为特点,通常累及骨髓、淋巴结、脾脏,其发病率较低,不易诊断。该文报道1例以冷凝集素综合征为首发表现的LPL/WM,行骨髓活组织病理学检查(活检)、血清免疫固定电泳、流式细胞学检验明确诊断,确诊后仅接受TD(沙利度胺、地塞米松)方案治疗。经治疗后患者病情好转,随访情况稳定。临床上对于疑为LPL/WM的患者,应尽快行骨髓活检、血清免疫固定电泳、流式细胞学检验等以尽早确诊,确诊后应根据患者病情选择适合的个体化治疗方案。 Lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia (LPL/WM)is a rare non-Hodgkin lymphoma,characterized as elevated levels of monoclonal IgM induced by lymphoplasmacytosis, constantly involvement with bone marrow,lymph node and spleen. LPL/WM have a low incidence and is diffi-cult to diagnose. In this article,we reported 1 case of typical LPL/WMwith cold agglutinin syndrome. The pa-tient received bone marrow biopsy,immunofixation electrophoresis and flow cytometry to confirm the diagnosis. He only received TD (thalidomide and dexamethasone)due to alleviated symptoms. After corresponding treat-ment,the patient was alleviated and his condition was stable during subsequent follow-up. For subjects suspec-ted with LPL/WM,bone marrow biopsy,immunofixation electrophoresis and flow cytometry should be per-formed for early diagnosis. After the diagnosis is confirmed,individualized therapy should be delivered accord-ing to the patients' conditions.
出处 《新医学》 2014年第12期838-840,共3页 Journal of New Medicine
关键词 淋巴浆细胞淋巴瘤 华氏巨球蛋白血症 冷凝集素综合征 Lymphoplasmacytic lymphoma Waldenstrom's macroglobulinemia Cold agglutinin syndrome
  • 相关文献

参考文献6

二级参考文献41

  • 1Berentsen S,Ulvestad E,Langholm R,吴敏(节译),陈会友(审校),田兆嵩(审校).86例原发性慢性冷凝集素疾病病人临床研究[J].国际输血及血液学杂志,2007,30(5):477-478. 被引量:3
  • 2Swerdlow SH,Campo E,Harris NL,et al.Vardiman JW World Health Organization classification of tumours of haematopoietic and lymphoid tissue[M].4th ed.Lyon:IARC Press,2008:194-195.
  • 3Treon SP,Hunter ZR,Aggarwal A,et al.Characterization of familial Waldenstrom's macroglobulinemia [J].Ann Oncol,2006,17(3):488-494.
  • 4Kristinsson SY,Bjorkholm M,Goldin LR,et al.Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients:a population-based study in Sweden[J].Blood,2008,112(8):3052-3056.
  • 5Kyle RA,Kumar S.The significance of monoclonal gammopathy of undetermined significance[J].Haematologica,2009,94(12):1641-1644.
  • 6Giordano TP,Henderson L,Landgren O,et al.Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus[J].JAMA,2007,297(18):2010-2017.
  • 7Koshiol J,Gridley G,Engels EA,et al.Chronic immune stimulation and subsequent Waldenstrom macroglobulinemia[J].Arch Intern Med,2008,168(17):1903-1909.
  • 8Kristinsson SY,Koshiol J,Bjorkholm M,et al.Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstr?m macroglobulinemia[J].J Natl Cancer Inst,2010,102(8):557-567.
  • 9Lindqvist EK,Goldin LR,Landgren O,et al.Personal and family history of immune-related conditions increase the risk of plasma cell disorders:a population-based study[J].Blood,2011,118(24):6284-6291.
  • 10Martin-Jimenez P,Garcia-Sanz R,Balanzategui A,et al.Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenstrom's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance[J].Haematologica,2007,92(5):635-642.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部